Calico Life Sciences

Calico Life Sciences LLC is an American biotechnology company with a focus on the biology of aging, attempting to devise interventions that may enable people to lead longer and healthier lives. It is a subsidiary of Alphabet Inc. Source

Category

Software

Headquarters

San Francisco, United States

Founded

2013

Calico Life Sciences across Glyph

• Frontier tech
• Leadership moves: 2 leaders
• Paydays: Pay schedule
• Official socials

Calico Life Sciences across Glyph: timeline

1. 2026-11-03 Official Careers: calicolabs.com/careers (Socials)
2. 2026-11-03 Official LinkedIn: calico-life-sciences-llc (Socials)
3. 2026-11-03 Official X: @calico (Socials)
4. 2026-05-21 Calico and Nexo Therapeutics sign small molecule discovery deal (Emerging)
5. 2025-11-12 AbbVie ends its decade-long partnership with Calico (Emerging)
6. 2025-06-26 Calico licenses Mabwell's IL-11 antibody for age-related disease (Emerging)
7. 2025-01-06 Calico's fosigotifator misses its goal in the HEALEY ALS platform trial (Emerging)

Sources

• emerging.fru.dev/companies/calico-life-sciences
• www.wikidata.org/wiki/Q14932155
• en.wikipedia.org/wiki/Calico_(company)
• socials.fru.dev/companies/calico-life-sciences